COVID-19 vaccine hesitancy in Egypt: a cross-sectional study

被引:2
|
作者
Shawki, May Ahmed [1 ]
Kamel, Ahmed [2 ]
Gamal, Shaza [2 ]
Abbassi, Maggie Magdy [2 ]
Farid, Samar Farghali [2 ]
Sabry, Nirmeen Ahmed [2 ,3 ]
机构
[1] Ain Shams Univ, Fac Pharm, Clin Pharm Dept, Cairo, Egypt
[2] Cairo Univ, Fac Pharm, Clin Pharm Dept, Giza, Egypt
[3] Cairo Univ, Fac Pharm, Clin Pharm Dept, Clin Pharm, Giza, Egypt
来源
关键词
COVID-19; Vaccine; Hesitancy; Survey;
D O I
10.3855/jidc.17794
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Coronavirus disease 2019 (COVID-19) vaccine hesitancy is a major problem. This study aimed to determine the factors associated Methodology: A cross-sectional survey-based study was conducted on a sample of the Egyptian population using an online survey distributed through social media platforms, including Facebook, WhatsApp, and LinkedIn. The questionnaire was composed of five parts: part I describing the research questionnaire and its aim, part II assessing the demographic data, part III assessing knowledge and attitude towards COVID-19 infection, and part IV and V evaluating knowledge regarding COVID-19 vaccines, factors affecting vaccine acceptance and participants' attitude toward vaccination. Regression models were used to assess factors associated with vaccine acceptability. Results: A total of 24376 responses were included in the statistical analysis. Females represented more than two-thirds of the study sample (70.5%,) and 18-24 years was the most commonly reported age group. Around one-third of the sample were healthcare professionals (HCPs). Only 14.3% of the participants received or registered to receive the vaccine, while 47% refused to be vaccinated. Regression analysis revealed that male gender, secondary education, older age, married or divorced status, presence of comorbidities, and higher level of knowledge regarding the vaccine were significantly associated with high vaccine acceptance. The most important vaccine attributes influencing vaccine selection in the current work were efficacy and safety. Conclusions: Vaccine hesitancy is currently a major challenge. Governments should design educational campaigns that provide trusted data related to vaccine efficacy and safety to encourage vaccination and enhance awareness.
引用
收藏
页码:1188 / +
页数:17
相关论文
共 50 条
  • [41] Hesitancy towards COVID-19 Vaccines: An Analytical Cross-Sectional Study
    Aloweidi, Abdelkarim
    Bsisu, Isam
    Suleiman, Aiman
    Abu-Halaweh, Sami
    Almustafa, Mahmoud
    Aqel, Mohammad
    Amro, Aous
    Radwan, Neveen
    Assaf, Dima
    Abdullah, Malak Ziyad
    Albataineh, Malak
    Mahasneh, Aya
    Badaineh, Ala'a
    Obeidat, Hala
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (10)
  • [42] Parental COVID-19 vaccine hesitancy for children with neurodevelopmental disorders: a cross-sectional survey
    Ali, Mohammad
    Proma, Tasnuva Shamarukh
    Tasnim, Zarin
    Islam, Md Ariful
    Urmi, Tania Akter
    Ahmed, Sohel
    Sarkar, Abu-sufian
    Bonna, Atia Sharmin
    Khan, Umme Salma
    TROPICAL MEDICINE AND HEALTH, 2022, 50 (01)
  • [43] Parental COVID-19 vaccine hesitancy for children with neurodevelopmental disorders: a cross-sectional survey
    Mohammad Ali
    Tasnuva Shamarukh Proma
    Zarin Tasnim
    Md. Ariful Islam
    Tania Akter Urmi
    Sohel Ahmed
    Abu-sufian Sarkar
    Atia Sharmin Bonna
    Umme Salma Khan
    Tropical Medicine and Health, 50
  • [44] COVID-19 vaccine hesitancy and attitudes of subjects with disability and their carers in Saudi Arabia: a cross-sectional study
    Sayed, Anwar A.
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [46] COVID-19 vaccine hesitancy and resistance in an urban Chinese population of Hong Kong: a cross-sectional study
    Yu, Branda Yee-Man
    Lam, Jason Chun-Sing
    Lam, Simon Ching
    Li, Yan
    Chen, Shucheng
    Lam, Mei Yuk
    Yeung, Wing-Fai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [47] COVID-19 vaccine hesitancy in six geopolitical zones in Nigeria: a cross-sectional survey
    Ogunbosi, Babatunde Oluwatosin
    Alao, Michael Abel
    Ibrahim, Olayinka Rasheed
    Ayuk, Adaeze Chikaodinaka
    Ibraheem, Rasheedat Mobolaji
    Odimegwu, Chioma Laura
    Ikwuka, David Chibuike
    Akintan, Patricia
    Morakinyo, OreOluwa
    Adeyemi, Ayomide Toluwanimi
    Jega, Ridwan Muhammad
    Olowookere, Temitayo Folorunso
    Bello, Olaseinde Emmanuel
    Owolabi, Bilkis Iyabo
    Chukwuyem, Abejegah
    Bukar, Lawan Maryah
    Rasaki, Aliu
    Issa, Amudalat
    Ewa, Atana Uket
    Oladokun, Regina
    Akinyinka, Olusegun Olusina
    PAN AFRICAN MEDICAL JOURNAL, 2022, 42
  • [48] Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study
    Sheikh, Naveen Siddique
    Touseef, Mumtaz
    Sultan, Riddah
    Cheema, Kanwal Hassan
    Cheema, Sidra Shafiq
    Sarwar, Afia
    Siddique, Haniya Zainab
    PLOS ONE, 2023, 18 (08):
  • [49] Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study
    Bucyibaruta, Georges
    Blangiardo, Marta
    Konstantinoudis, Garyfallos
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (10) : 1071 - 1081
  • [50] Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study
    Steinmetz, Lara
    BMC PUBLIC HEALTH, 2022, 22 (01)